HowShorted

How shorted is INOVIO PHARMACEUTICALS, INC.?

More shorted than 97% of the 2,877 ranked US companies

23.22%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
+2.13
5 reports (~10 weeks)
+0.09
Aggregate net short position time series for INOVIO PHARMACEUTICALS, INC.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202623.22%+2.13
15 Jul 202621.09%−0.68
30 Jun 202621.77%−1.68
15 Jun 202623.45%−0.10
29 May 202623.55%+0.42
15 May 202623.13%+2.53
30 Apr 202620.60%+2.12
15 Apr 202618.48%+4.17
31 Mar 202614.31%−1.26
13 Mar 202615.57%−4.89
27 Feb 202620.46%−0.85
13 Feb 202621.31%−1.93
30 Jan 202623.24%+1.41
15 Jan 202621.83%+3.41
31 Dec 202518.42%+0.79
15 Dec 202517.63%+1.52
28 Nov 202516.11%+0.69
14 Nov 202515.42%−0.03
31 Oct 202515.45%+1.19
15 Oct 202514.26%−0.09
30 Sep 202514.35%+0.25
15 Sep 202514.10%+1.69
29 Aug 202512.41%+1.81
15 Aug 202510.60%−3.30
31 Jul 202513.90%–

Frequently asked questions

How shorted is INOVIO PHARMACEUTICALS, INC. right now?
23.22% of INOVIO PHARMACEUTICALS, INC.'s (INO) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.